Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Chapel Hill, NC
SEC filing record 1 source field available
Fiscal year end
31 December
TENAX THERAPEUTICS, INC. has filed 987 SEC EDGAR filings since 02 Aug 1996

SEC filing history

Showing 701-725 of 819 matching filings.

Per page
25
Current page
29
PRE 14A File 001-34600

PRELIMINARY PROXY STATEMENT

Filing date
20 Jul 2012
Reporting date
31 Aug 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Jul 2012
Reporting date
01 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34600

CURRENT REPORT

Filing date
15 Jun 2012
Reporting date
14 Jun 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2012
Reporting date
01 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2012
Reporting date
01 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2012
Reporting date
01 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Jun 2012
Reporting date
01 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 May 2012
Reporting date
01 May 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Apr 2012
Reporting date
15 Apr 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
16 Mar 2012
Reporting date
15 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34600

FORM 8-K

Filing date
16 Mar 2012
Reporting date
15 Mar 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34600

QUARTERLY REPORT

Filing date
15 Mar 2012
Reporting date
31 Jan 2012
Next action
Verify source filing
8-K File 001-34600

CURRENT REPORT

Filing date
01 Mar 2012
Reporting date
27 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Feb 2012
Reporting date
15 Feb 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
06 Feb 2012
Reporting date
16 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
06 Feb 2012
Reporting date
24 Jun 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
06 Feb 2012
Reporting date
20 Oct 2009
SEC evidence
Open document Open filing
Next action
Verify source filing
3

PRIMARY DOCUMENT

Filing date
20 Jan 2012
Reporting date
16 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
17 Jan 2012
Reporting date
15 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34600

CURRENT REPORT

Filing date
11 Jan 2012
Reporting date
11 Jan 2012
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Dec 2011
Reporting date
15 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34600

CURRENT REPORT

Filing date
19 Dec 2011
Reporting date
16 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-34600

QUARTERLY REPORT

Filing date
15 Dec 2011
Reporting date
31 Oct 2011
Next action
Verify source filing
8-K/A File 001-34600

CURRENT REPORT

Filing date
13 Dec 2011
Reporting date
08 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-165733

PROSPECTUS SUPPLEMENT

Filing date
09 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .